Diabetes 54:2343-2350, 2005
© 2005 by the American Diabetes Association, Inc.
Physiological Increases in Uncoupling Protein 3 Augment Fatty Acid Oxidation and Decrease Reactive Oxygen Species Production Without Uncoupling Respiration in Muscle Cells
J. Darcy MacLellan1,
Martin F. Gerrits1,
Adrienne Gowing1,
Peter J.S. Smith2,
Michael B. Wheeler3, and
Mary-Ellen Harper1
1 Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
2 BioCurrents Research Center, Program in Molecular Physiology, Marine Biological Laboratory, Woods Hole, Massachusetts
3 Departments of Medicine and Physiology, University of Toronto, Toronto, Ontario, Canada
Decreased uncoupling protein (UCP)3 is associated with insulin resistance in muscle of pre-diabetic and diabetic individuals, but the function of UCP3 remains unclear. Our goal was to elucidate mechanisms underlying the negative correlation between UCP3 and insulin resistance in muscle. We determined effects of physiologic UCP3 overexpression on glucose and fatty acid oxidation and on mitochondrial uncoupling and reactive oxygen species (ROS) production in L6 muscle cells. An adenoviral construct caused a 2.2- to 2.5-fold increase in UCP3 protein. Palmitate oxidation was increased in muscle cells incubated under normoglycemic or hyperglycemic conditions, whereas adenoviral green fluorescent protein infection or chronic low doses of the uncoupler dinitrophenol had no effect. Increased UCP3 did not affect glucose oxidation, whereas dinitrophenol and insulin treatments caused increases. Basal oxygen consumption, assessed in situ using self-referencing microelectrodes, was not significantly affected, whereas dinitrophenol caused increases. Mitochondrial membrane potential was decreased by dinitrophenol but was not affected by increased UCP3 expression. Finally, mitochondrial ROS production decreased significantly with increased UCP3 expression. Results are consistent with UCP3 functioning to facilitate fatty acid oxidation and minimize ROS production. As impaired fatty acid metabolism and ROS handling are important precursors in muscular insulin resistance, UCP3 is an important therapeutic target in type 2 diabetes.
Address correspondence and reprint requests to Mary-Ellen Harper, PhD, Faculty of Medicine, University of Ottawa, 451 Smyth Rd., Ottawa, ON, Canada K1H 8M5. E-mail: mharper{at}uottawa.ca
Abbreviations:
CPT, carnitine palmitoyl transferase; CoASH, uncombined CoA; DCFDA, 5-(and 6)-carboxy-2',7'-dichlorohydofluorescein diacetate; GFP, green fluorescent protein; MTE1, mitochondrial thioesterase-1; ROS, reactive oxygen species; TMRE, tetramethylrhodamine ethyl ester; UCP, uncoupling protein

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Pieter de Lange, M. Moreno, E. Silvestri, A. Lombardi, F. Goglia, and A. Lanni
Fuel economy in food-deprived skeletal muscle: signaling pathways and regulatory mechanisms
FASEB J,
November 1, 2007;
21(13):
3431 - 3441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Anderson, H. Yamazaki, and P. D. Neufer
Induction of Endogenous Uncoupling Protein 3 Suppresses Mitochondrial Oxidant Emission during Fatty Acid-supported Respiration
J. Biol. Chem.,
October 26, 2007;
282(43):
31257 - 31266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. McCarthy, J. L. Andrews, E. L. McDearmon, K. S. Campbell, B. K. Barber, B. H. Miller, J. R. Walker, J. B. Hogenesch, J. S. Takahashi, and K. A. Esser
Identification of the circadian transcriptome in adult mouse skeletal muscle
Physiol Genomics,
September 11, 2007;
31(1):
86 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Raichur, P. Lau, B. Staels, and G. E O Muscat
Retinoid-related orphan receptor {gamma} regulates several genes that control metabolism in skeletal muscle cells: links to modulation of reactive oxygen species production
J. Mol. Endocrinol.,
July 1, 2007;
39(1):
29 - 44.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. X. Rong, Y. Qiu, M. K. Hansen, L. Zhu, V. Zhang, M. Xie, Y. Okamoto, M. D. Mattie, H. Higashiyama, S. Asano, et al.
Adipose Mitochondrial Biogenesis Is Suppressed in db/db and High-Fat Diet-Fed Mice and Improved by Rosiglitazone
Diabetes,
July 1, 2007;
56(7):
1751 - 1760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fernstrom, L. Bakkman, M. Tonkonogi, I. G. Shabalina, Z. Rozhdestvenskaya, C. M. Mattsson, J. K. Enqvist, B. Ekblom, and K. Sahlin
Reduced efficiency, but increased fat oxidation, in mitochondria from human skeletal muscle after 24-h ultraendurance exercise
J Appl Physiol,
May 1, 2007;
102(5):
1844 - 1849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. K. Heilbronn, S. K. Gan, N. Turner, L. V. Campbell, and D. J. Chisholm
Markers of Mitochondrial Biogenesis and Metabolism Are Lower in Overweight and Obese Insulin-Resistant Subjects
J. Clin. Endocrinol. Metab.,
April 1, 2007;
92(4):
1467 - 1473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Piotrkowski, C. G. Fraga, and E. M. V. de Cavanagh
Mitochondrial function and nitric oxide metabolism are modified by enalapril treatment in rat kidney
Am J Physiol Regulatory Integrative Comp Physiol,
April 1, 2007;
292(4):
R1494 - R1501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sebastian, L. Herrero, D. Serra, G. Asins, and F. G. Hegardt
CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance
Am J Physiol Endocrinol Metab,
March 1, 2007;
292(3):
E677 - E686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Bezaire, E. L. Seifert, and M.-E. Harper
Uncoupling protein-3: clues in an ongoing mitochondrial mystery
FASEB J,
February 1, 2007;
21(2):
312 - 324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. de Lange, P. Farina, M. Moreno, M. Ragni, A. Lombardi, E. Silvestri, L. Burrone, A. Lanni, and F. Goglia
Sequential changes in the signal transduction responses of skeletal muscle following food deprivation
FASEB J,
December 1, 2006;
20(14):
2579 - 2581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Pedraza, M. Rosell, J. Villarroya, R. Iglesias, F. J. Gonzalez, G. Solanes, and F. Villarroya
Developmental and Tissue-Specific Involvement of Peroxisome Proliferator-Activated Receptor-{alpha} in the Control of Mouse Uncoupling Protein-3 Gene Expression
Endocrinology,
October 1, 2006;
147(10):
4695 - 4704.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Myers, S.-C. M. Wang, and G. E. O. Muscat
The Chicken Ovalbumin Upstream Promoter-Transcription Factors Modulate Genes and Pathways Involved in Skeletal Muscle Cell Metabolism
J. Biol. Chem.,
August 25, 2006;
281(34):
24149 - 24160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. W. Cline
Tough love: left out in the cold, but not abandoned, by UCP3
J Appl Physiol,
July 1, 2006;
101(1):
12 - 13.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Barger, B. M. Barnes, and B. B. Boyer
Regulation of UCP1 and UCP3 in arctic ground squirrels and relation with mitochondrial proton leak
J Appl Physiol,
July 1, 2006;
101(1):
339 - 347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Costford, S. N. Chaudhry, M. Salkhordeh, and M.-E. Harper
Effects of the presence, absence, and overexpression of uncoupling protein-3 on adiposity and fuel metabolism in congenic mice
Am J Physiol Endocrinol Metab,
June 1, 2006;
290(6):
E1304 - E1312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Gable, J. W. Stephens, J. A. Cooper, G. J. Miller, and S. E. Humphries
Variation in the UCP2-UCP3 Gene Cluster Predicts the Development of Type 2 Diabetes in Healthy Middle-Aged Men.
Diabetes,
May 1, 2006;
55(5):
1504 - 1511.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mogensen, M. Bagger, P. K. Pedersen, M. Fernstrom, and K. Sahlin
Cycling efficiency in humans is related to low UCP3 content and to type I fibres but not to mitochondrial efficiency
J. Physiol.,
March 15, 2006;
571(3):
669 - 681.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Diabetes Association.
|
|
| |
|